Language of the Report – English
ومع ذلك، قد يكون التقرير متوفرًا بالعربية مقابل تكلفة إضافية.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Influenza Vaccine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Quadrivalent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Trivalent
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Egg-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cell-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Age Group
8.1 Pediatric
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Adult
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Injection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Nasal Spray
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AstraZeneca plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 CSL Limited
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Daiichi Sankyo Company Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Emergent BioSolutions Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F. Hoffmann-La Roche AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Gamma Vaccines Pty Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Merck & Co. Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Novartis AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Pfizer Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Sanofi
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 SINOVAC
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
List of Figures
Figure 1: Global: Influenza Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Influenza Vaccine Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Influenza Vaccine Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Influenza Vaccine Market: Breakup by Vaccine Type (in %), 2022
Figure 5: Global: Influenza Vaccine Market: Breakup by Technology (in %), 2022
Figure 6: Global: Influenza Vaccine Market: Breakup by Age Group (in %), 2022
Figure 7: Global: Influenza Vaccine Market: Breakup by Route of Administration (in %), 2022
Figure 8: Global: Influenza Vaccine Market: Breakup by Region (in %), 2022
Figure 9: Global: Influenza Vaccine (Quadrivalent) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Influenza Vaccine (Quadrivalent) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Influenza Vaccine (Trivalent) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Influenza Vaccine (Trivalent) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Influenza Vaccine (Egg-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Influenza Vaccine (Egg-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Influenza Vaccine (Cell-based) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Influenza Vaccine (Cell-based) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Influenza Vaccine (Pediatric) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Influenza Vaccine (Pediatric) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Influenza Vaccine (Adult) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Influenza Vaccine (Adult) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Influenza Vaccine (Injection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Influenza Vaccine (Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Influenza Vaccine (Nasal Spray) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Influenza Vaccine (Nasal Spray) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: North America: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: North America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: United States: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: United States: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Canada: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Canada: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Asia-Pacific: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Asia-Pacific: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: China: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: China: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Japan: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Japan: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: India: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: India: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: South Korea: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: South Korea: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Australia: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Australia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Indonesia: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Indonesia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Europe: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Europe: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Germany: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Germany: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: France: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: France: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: United Kingdom: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: United Kingdom: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Italy: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Italy: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Spain: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Spain: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Russia: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Russia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Latin America: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Latin America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Brazil: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Brazil: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Mexico: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Mexico: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Middle East and Africa: Influenza Vaccine Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Middle East and Africa: Influenza Vaccine Market: Breakup by Country (in %), 2022
Figure 73: Middle East and Africa: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Global: Influenza Vaccine Industry: SWOT Analysis
Figure 75: Global: Influenza Vaccine Industry: Value Chain Analysis
Figure 76: Global: Influenza Vaccine Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Influenza Vaccine Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Influenza Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
Table 3: Global: Influenza Vaccine Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Influenza Vaccine Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
Table 5: Global: Influenza Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 6: Global: Influenza Vaccine Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Influenza Vaccine Market: Competitive Structure
Table 8: Global: Influenza Vaccine Market: Key Players